Friday, August 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Dividends

Nemetschek Proposes Significant Dividend Hike Following Record Revenue

Kennethcix by Kennethcix
March 16, 2026
in Dividends, Earnings, MDAX & SDAX, Tech & Software
0
Nemetschek Stock
0
SHARES
26
VIEWS
Share on FacebookShare on Twitter

The Nemetschek Group has announced a proposal to its shareholders for a substantial increase in its annual dividend. The software company is recommending a payout of €0.68 per share, marking a sharp 24% rise compared to the previous year’s distribution. This move comes on the heels of the firm surpassing the one-billion-euro revenue milestone for the first time.

Operational Strength Underpins Payout

This generous dividend proposal is grounded in a year of exceptional financial performance. For the 2025 fiscal year, Nemetschek achieved currency-adjusted group revenue of approximately €1.19 billion, representing robust growth of 22.6%. Profitability metrics were even stronger, with EBITDA expanding at a faster rate. The company’s EBITDA margin consequently improved, reaching 31.2%. Management’s decision to raise the shareholder return signals confidence in the sustainability of this earnings power.

Strategic Initiatives Fuel Performance

The company’s strategic focus has been a key driver of its solid results. A deliberate shift toward subscription and Software-as-a-Service (SaaS) revenue models, coupled with continued international expansion, has provided a stable foundation for growth. Looking forward, Nemetschek is channeling investments into areas like artificial intelligence, cloud-based solutions, and digital twin technology to maintain its momentum.

Should investors sell immediately? Or is it worth buying Nemetschek?

Financing this strategy is a newly arranged syndicated credit facility worth €500 million. This financing replaced previous bilateral credit lines and is reported to offer more favorable terms, providing the company with flexible capital for its initiatives.

Despite these operational successes, the company’s share price tells a different story. The stock, currently trading at €69.25, remains significantly depressed, showing a decline of roughly 40% over a one-year period and well below its prior-year levels. While the dividend increase alone is unlikely to fully reverse this market underperformance, it serves as a clear indicator that the underlying business remains healthy and cash-generative.

Ad

Nemetschek Stock: Buy or Sell?! New Nemetschek Analysis from August 7 delivers the answer:

The latest Nemetschek figures speak for themselves: Urgent action needed for Nemetschek investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 7.

Nemetschek: Buy or sell? Read more here...

Tags: Nemetschek
Kennethcix

Kennethcix

Related Posts

Kioxia Stock
Asian Markets

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

August 7, 2026
OHB SE Stock
Earnings

OHB’s Two-Faced Half-Year: Record Orders Mask a Profit Squeeze That Spooked the Market

August 7, 2026
Micron Technology Stock
Analysis

Micron’s 30% Slide: A Story of External Noise, Not Internal Decay

August 7, 2026
Next Post
Onco-Innovations Stock

Onco-Innovations Secures Funding to Advance Cancer Drug Candidate

Glencore Stock

Glencore Navigates a Trio of Strategic Challenges

Newmont Stock

Navigating a Challenging Transition: Newmont's 2026 Outlook

Recommended

CRWD stock news

Analyst Increases Price Target for Meta Platforms Expresses Optimism for Future Growth

3 years ago
Albemarle Stock

Albemarle’s Lithium Challenge: Navigating Market Headwinds with Surprising Resilience

12 months ago
IO Biotech Stock

A Critical Juncture for IO Biotech Shares

8 months ago
Healwell AI Stock

Healwell AI Charts a New Course: Acquisition Fuels Revenue Surge Amidst Profitability Challenge

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

MSCI World ETF: Index Provider Rewrites the Rulebook for Fast-Moving Stocks

Airbus’ Paradox: A Slightly Smaller Forecast That Nobody Seems to Mind

Almonty Industries Rebounds From Index-Driven Exit as Tungsten Calculus Shifts Westward

OHB’s Two-Faced Half-Year: Record Orders Mask a Profit Squeeze That Spooked the Market

SK Hynix’s Split Personality: Record Earnings, a Thin-Tape Glitch, and the $263 Billion Question

Micron’s 30% Slide: A Story of External Noise, Not Internal Decay

Trending

Bitcoin Stock
Newsletter

Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

by Stephanie Dugan
August 7, 2026
0

Dear readers, Yesterday the debate in Washington was whether the Fed needed to hike again to tame...

Kioxia Stock

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

August 7, 2026
FALLBACK Stock

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

August 7, 2026
MSCI World ETF Stock

MSCI World ETF: Index Provider Rewrites the Rulebook for Fast-Moving Stocks

August 7, 2026
Airbus Stock

Airbus’ Paradox: A Slightly Smaller Forecast That Nobody Seems to Mind

August 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins
  • Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor
  • French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com